These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 18275790)

  • 21. Increased breast calcifications in women with ESRD on dialysis: implications for breast cancer screening.
    Castellanos M; Varma S; Ahern K; Grosso SJ; Buchbinder S; D'Angelo D; Raia C; Kleiner M; Elsayegh S
    Am J Kidney Dis; 2006 Aug; 48(2):301-6. PubMed ID: 16860197
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardiovascular calcifications in pediatric patients receiving maintenance dialysis.
    Sheth RD; Perez MD; Goldstein SL
    Pediatr Nephrol; 2003 Aug; 18(8):810-3. PubMed ID: 12774220
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The assay of the hypocalcemic PTH fragment inhibitor with PTH provides a more accurate assessment of renal osteodystrophy compared to the intact PTH assay.
    Cantor T; Sci B
    Nefrologia; 2003; 23 Suppl 2():69-72. PubMed ID: 12778858
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Re-evaluation of risks associated with hyperphosphatemia and hyperparathyroidism in dialysis patients: recommendations for a change in management.
    Block GA; Port FK
    Am J Kidney Dis; 2000 Jun; 35(6):1226-37. PubMed ID: 10845841
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum magnesium level and arterial calcification in end-stage renal disease.
    Meema HE; Oreopoulos DG; Rapoport A
    Kidney Int; 1987 Sep; 32(3):388-94. PubMed ID: 3669498
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Does a plain X-ray of the pelvis predict arterial complications in renal transplantation? A prospective study.
    Aalten J; Dekker HM; van der Vliet JA; Hoitsma AJ
    Nephrol Dial Transplant; 2011 Jun; 26(6):2007-12. PubMed ID: 21097647
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence and correlates of vascular disease at ultrasound examination in patients on hemodialysis.
    Miguel SB; Miguel JB; Velarde LG; Sampaio Ede A; Matos JP; Lugon JR
    Arq Bras Cardiol; 2011 Apr; 96(4):260-5. PubMed ID: 21359477
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The progression of vascular calcification and serum osteoprotegerin levels in patients on long-term hemodialysis.
    Nitta K; Akiba T; Uchida K; Kawashima A; Yumura W; Kabaya T; Nihei H
    Am J Kidney Dis; 2003 Aug; 42(2):303-9. PubMed ID: 12900812
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Factors associated with various arterial calcifications in haemodialysis patients.
    Gelev S; Spasovski G; Trajkovski Z; Damjanovski G; Amitov V; Selim G; Dzekova P; Sikole A
    Prilozi; 2008 Dec; 29(2):185-199. PubMed ID: 19259046
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiovascular calcification in end-stage renal disease.
    Salusky IB; Goodman WG
    Nephrol Dial Transplant; 2002 Feb; 17(2):336-9. PubMed ID: 11812902
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Calcium-sensing receptor, calcimimetics, and cardiovascular calcifications in chronic kidney disease.
    Torres PA; De Broe M
    Kidney Int; 2012 Jul; 82(1):19-25. PubMed ID: 22437409
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum albumin and von Willebrand factor: possible markers for early detection of vascular damage in children undergoing peritoneal dialysis.
    Cetın N; Sav NM; Karabel D; Yildirim A; Yıldız B
    Clin Invest Med; 2016 Sep; 39(4):E111-9. PubMed ID: 27619398
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Structural changes and vascular calcifications in uremia].
    Caramelo C; Goicoechea M; Albalate M; Nieto L; Melero R; Berlanga JR; López MD; González Pacheco F; Marrón B; Alvarez Arroyo MV; Castilla MA; Yagüe S; Deudero JJ; Ortiz A
    Nefrologia; 2001; 21(6):538-47. PubMed ID: 11881423
    [No Abstract]   [Full Text] [Related]  

  • 35. Vascular calcification in chronic kidney disease: a clinical review.
    Eddington H; Sinha S; Kalra PA
    J Ren Care; 2009 Mar; 35 Suppl 1():45-50. PubMed ID: 19222731
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New worldwide trends in presentation of renal osteodystrophy and its relationship to parathyroid hormone levels.
    Gal-Moscovici A; Popovtzer MM
    Clin Nephrol; 2005 Apr; 63(4):284-9. PubMed ID: 15847255
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Skeletal abnormalities in chronic renal insufficiency before and during maintenance hemodialysis.
    Ritz E; Krempien B; Mehls O; Malluche H
    Kidney Int; 1973 Aug; 4(2):116-27. PubMed ID: 4790866
    [No Abstract]   [Full Text] [Related]  

  • 38. Arteriosclerosis, vascular calcifications and cardiovascular disease in uremia.
    London GM; Marchais SJ; Guérin AP; Métivier F
    Curr Opin Nephrol Hypertens; 2005 Nov; 14(6):525-31. PubMed ID: 16205470
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mineral and bone disorders in patients on dialysis: physiology and clinical consequences.
    McCarley PB; Arjomand M
    Nephrol Nurs J; 2008; 35(1):59-64. PubMed ID: 18372764
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PTH and bone markers of renal osteodystrophy in predialysis chronic renal failure.
    Coen G; Mazzaferro S; Ballanti P; Bonucci E
    J Endocrinol Invest; 1992; 15(9 Suppl 6):129-33. PubMed ID: 1300330
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.